相关实验视频
Updated: May 23, 2025

07:58
Characterizing Mutational Load and Clonal Composition of Human Blood
Published on: July 11, 2019
7.3K
用体内表皮转移进行的克隆追踪揭示了血液衰老的动态
Michael Scherer1,2, Indranil Singh3,4, Martina Maria Braun1,5
1Computational Biology and Health Genomics, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
Nature
|May 21, 2025
概括
研究人员开发了EPI-Clone,这是一种使用DNA甲基化追踪干细胞分化和身份的无转基因方法. 这种方法可以在小鼠和人类中进行大规模,准确的血系干细胞追踪.
科学领域:
- * 分子生物学
- * 遗传学
- * 发育生物学
背景情况:
- *目前的干细胞克隆追踪方法依赖于基因工程或稀疏的DNA变异,限制了它们的应用.
- *DNA甲基化模式可以反映细胞分化和随机表皮化,为血统追踪提供潜力.
- * 需要无转基因,可扩展的方法来跟踪分化过程中的干细胞克隆.
研究的目的:
- * 发现和验证用于跟踪干细胞克隆身份和分化的DNA甲基化模式.
- * 开发一种无转基因的大规模单细胞血统追踪方法.
- 用这种方法研究小鼠和人类的造血干细胞衰老.
主要方法:
- 在单个CpG分辨率下针对单细胞DNA甲基化.
- * 开发EPI-克隆,一种新的无转基因血统追踪方法.
- * 应用EPI-Clone来分析230,358个单细胞中的小鼠和人类的数百个克隆分化轨迹.
主要成果:
- * 特定CpG位点的DNA甲基化准确地反映了细胞分化和克隆特征.
- * EPI-Clone成功捕获了小鼠和人类的广泛克隆分化轨迹.
- 在血液形成中与年龄相关的克隆扩张,包括带有和没有驱动突变的细胞,在老鼠干细胞中显示出受限制的髓质偏差.
结论:
- * EPI-Clone提供准确,无转基因和可扩展的单细胞血统追踪.
- 在分化和衰老过程中,DNA甲基化是剖析克隆动态的强大工具.
- 这些发现为老化血液形成的克隆结构提供了新的洞察力.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K

